Smithfield Trust’s DexCom DXCM Stock Holding History

Smithfield Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$151K	Buy	2,430 +2,350	+2,938%	+$164K	0.01%	416
2025 Q4	$6K	Hold	80	–	–	﹤0.01%	958
2025 Q3	$6K	Hold	80	–	–	﹤0.01%	931
2025 Q2	$6K	Hold	80	–	–	﹤0.01%	939
2025 Q1	$6K	Hold	80	–	–	﹤0.01%	941
2024 Q4	$6K	Hold	80	–	–	﹤0.01%	954
2024 Q3	$6K	Hold	80	–	–	﹤0.01%	917
2024 Q2	$10K	Sell	80 -245	-75%	-$31K	﹤0.01%	815
2024 Q1	$46K	Hold	325	–	–	﹤0.01%	576
2023 Q4	$40K	Buy	325 +165	+103%	+$16.9K	﹤0.01%	582
2023 Q3	$15K	Hold	160	–	–	﹤0.01%	740
2023 Q2	$20K	Hold	160	–	–	﹤0.01%	693
2023 Q1	$19K	Hold	160	–	–	﹤0.01%	673
2022 Q4	$19K	Hold	160	–	–	﹤0.01%	656
2022 Q3	$12K	Hold	160	–	–	﹤0.01%	733
2022 Q2	$12K	Hold	160	–	–	﹤0.01%	774
2022 Q1	$20K	Hold	160	–	–	﹤0.01%	700
2021 Q4	$21K	Hold	160	–	–	﹤0.01%	700
2021 Q3	$21K	Hold	160	–	–	﹤0.01%	702
2021 Q2	$17K	Hold	160	–	–	﹤0.01%	726
2021 Q1	$14K	Hold	160	–	–	﹤0.01%	769
2020 Q4	$15K	Sell	160 -2,080	-93%	-$186K	﹤0.01%	732
2020 Q3	$231K	Hold	2,240	–	–	0.02%	259
2020 Q2	$227K	Buy	2,240 +1,200	+115%	+$107K	0.02%	255
2020 Q1	$70K	Buy	+1,040	New	+$64.7K	0.01%	390

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Smithfield Trust's DXCM Position: Q1 2026 in Review

Smithfield Trust increased its DexCom (DXCM) stake by 2,938% in Q1 2026, buying an estimated $164K and bringing the position to 2,430 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #416.

Smithfield Trust first reported a position in DXCM in Q1 2020 and has held it in 25 quarters since. The position peaked at $231K in Q3 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Smithfield Trust held 2,430 shares of DexCom worth $151K as of Q1 2026.
Smithfield Trust bought 2,350 DexCom shares in Q1 2026, an estimated $164K.
DexCom made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #416 holding.
Smithfield Trust first reported a position in DexCom in Q1 2020 and has held it in 25 quarters since.
Smithfield Trust's DexCom position peaked at $231K in Q3 2020.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.